23andMe Holding Co. (NASDAQ:ME) Q2 2023 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Wade Walke - Vice President-Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Joe Selsavage - Interim Chief Financial Officer & Accounting Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants Tiago Fauth - Credit Suisse Steven Mah - Cowen Operator Good day, and thank you for standing by. Welcome to the 23andMe's Fiscal Year 2023 Second Quarter Ea ...